![美股盘前:股指期货转跌 美元指数触及106 金价跌至2300美元附近](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEJ5K0JR_L.jpg)
注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Sangamo Therapeutics Inc是一家临床阶段的基因组医学公司。该公司专注于利用其优化的锌指(ZF)技术,一种用于开发基因组药物的差异化工具,包括同种异体细胞疗法和体内基因组工程疗法。其候选产品包括Isaralgagene civaparvovec,也称为ST-920,是其自有的基因治疗候选产品,用于治疗法布里病;SAR445136,ZF核酸酶,是一种基因编辑细胞治疗候选产品,用于治疗镰状细胞病(SCD);TX200,是其自有的嵌合抗原受体(CAR)工程调节性T细胞(CAR-Treg),该细胞治疗候选产品用于预防HLA-A2错配肾移植中免疫介导排斥;Giroctocogene fitelparvovec,也称为SB-525,是一种用于治疗中度至重度血友病A的基因治疗候选产品。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
H. Stewart Parker | 68 | 2014 | Independent Chairwoman of the Board |
Alexander D. Macrae | 61 | 2016 | CEO, President & Director |
Jef D. Boeke | - | 2019 | Member of Scientific Advisory Board |
Steven W. Pipe | - | 2019 | Member of Scientific Advisory Board |
Karen L. Smith | 56 | 2018 | Independent Director |
J. Fraser Wright | - | 2019 | Member of Scientific Advisory Board |
John H. Markels | 58 | 2020 | Independent Director |
Robert F. Carey | 65 | 2016 | Independent Director |
Samuel A. J. R. Aparicio | - | 2019 | Member of Scientific Advisory Board |
James R. Meyers | 59 | 2019 | Independent Director |
Douglas Higgs | - | 2019 | Member of Scientific Advisory Board |
Megan Levings | - | 2019 | Member of Scientific Advisory Board |
Michael Grunstein | - | 2019 | Member of Scientific Advisory Board |
Robert J. Desnick | - | 2019 | Member of Scientific Advisory Board |
Stuart L. Schreiber | 68 | 2019 | Member of Scientific Advisory Board |
Roger D. Kornberg | 77 | 2019 | Member of Scientific Advisory Board |
Margaret A. Horn | 61 | 2022 | Independent Director |
Frank S. Walsh | - | 2019 | Member of Scientific Advisory Board |
Kenneth J. Hillan | 63 | 2020 | Independent Director |
Courtney Beers | 54 | 2022 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核